These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11386493)

  • 1. The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa.
    Mitchell JE; Fletcher L; Hanson K; Mussell MP; Seim H; Crosby R; Al-Banna M
    J Clin Psychopharmacol; 2001 Jun; 21(3):298-304. PubMed ID: 11386493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.
    Goldstein DJ; Wilson MG; Ascroft RC; al-Banna M
    Int J Eat Disord; 1999 Jan; 25(1):19-27. PubMed ID: 9924649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
    Romano SJ; Halmi KA; Sarkar NP; Koke SC; Lee JS
    Am J Psychiatry; 2002 Jan; 159(1):96-102. PubMed ID: 11772696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open trial of fluoxetine for adolescents with bulimia nervosa.
    Kotler LA; Devlin MJ; Davies M; Walsh BT
    J Child Adolesc Psychopharmacol; 2003; 13(3):329-35. PubMed ID: 14642021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
    Arch Gen Psychiatry; 1992 Feb; 49(2):139-47. PubMed ID: 1550466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.
    Goldstein DJ; Wilson MG; Thompson VL; Potvin JH; Rampey AH
    Br J Psychiatry; 1995 May; 166(5):660-6. PubMed ID: 7620754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial.
    Mitchell JE; Agras S; Crow S; Halmi K; Fairburn CG; Bryson S; Kraemer H
    Br J Psychiatry; 2011 May; 198(5):391-7. PubMed ID: 21415046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa.
    Rissanen A; Naukkarinen H; Virkkunen M; Rawlings RR; Linnoila M
    J Clin Psychopharmacol; 1998 Feb; 18(1):26-32. PubMed ID: 9472839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking.
    Kornreich C; Dan B; Verbanck P; Fontaine E; Pelc I
    Biol Psychiatry; 1998 Feb; 43(4):310-1. PubMed ID: 9513743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ; Goldfein JA; Petkova E; Jiang H; Raizman PS; Wolk S; Mayer L; Carino J; Bellace D; Kamenetz C; Dobrow I; Walsh BT
    Obes Res; 2005 Jun; 13(6):1077-88. PubMed ID: 15976151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome.
    Goldbloom DS; Olmsted M; Davis R; Clewes J; Heinmaa M; Rockert W; Shaw B
    Behav Res Ther; 1997 Sep; 35(9):803-11. PubMed ID: 9299800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of bulimia nervosa in a primary care setting.
    Walsh BT; Fairburn CG; Mickley D; Sysko R; Parides MK
    Am J Psychiatry; 2004 Mar; 161(3):556-61. PubMed ID: 14992983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change.
    Goldbloom DS; Olmsted MP
    Am J Psychiatry; 1993 May; 150(5):770-4. PubMed ID: 8480824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2001; 2003(4):CD003391. PubMed ID: 11687198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-help for bulimia nervosa: a randomized controlled trial.
    Carter JC; Olmsted MP; Kaplan AS; McCabe RE; Mills JS; Aimé A
    Am J Psychiatry; 2003 May; 160(5):973-8. PubMed ID: 12727703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the efficacy of supervised cognitive behavioral self-help bulimia nervosa.
    Cooper PJ; Coker S; Fleming C
    J Psychosom Res; 1996 Mar; 40(3):281-7. PubMed ID: 8861124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication and psychotherapy in the treatment of bulimia nervosa.
    Walsh BT; Wilson GT; Loeb KL; Devlin MJ; Pike KM; Roose SP; Fleiss J; Waternaux C
    Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
    Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
    Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.